FDA is not going to get its hands on an expected extra influx of user fees from the device industry come Oct. 1 as a result of an emergency spending bill heading towards enactment. How long the additional funds will remain untouchable by the agency remains to be seen.
FDA is slated to receive approximately $30 million in additional revenue from device companies in user fees for fiscal year...